21.961 articles found

Levodopa therapy monitoring in patients with Parkinson disease: a kinetic-dynamic approach.

Contin M, Riva R, Martinelli P, Albani F, Avoni P, Baruzzi A.

Ther Drug Monit · 2001-12-01

DOI: 10.1097/00007691-200112000-00005PMID: 11802094

Efficacy and safety of zotepine for the treatment of Taiwanese schizophrenic patients: a double-blind comparison with haloperidol.

Hwang TJ, Lin SK, Lin HN.

J Formos Med Assoc · 2001-12-01

PMID: 11802520

Duodenal levodopa infusion in Parkinson's disease--long-term experience.

Nilsson D, Nyholm D, Aquilonius SM.

Acta Neurol Scand · 2001-12-01

DOI: 10.1034/j.1600-0404.2001.00153.xPMID: 11903087

Bilateral deep brain stimulation (DBS) of the subthalamic nucleus (STN) or the globus pallidus interna (GPi) for treatment of advanced Parkinson's disease.

Check source for author details

Tecnologica MAP Suppl · 2001-12-01

PMID: 11933935

Harnessing the immune system for neuroprotection: therapeutic vaccines for acute and chronic neurodegenerative disorders.

Schwartz M.

Cell Mol Neurobiol · 2001-12-01

DOI: 10.1023/a:1015139718466PMID: 12043837

[Gene therapy for Parkinson's disease: studies in animal models].

Muramatsu S.

Rinsho Shinkeigaku · 2001-12-01

PMID: 12235825

Lentiviral-mediated growth factor gene therapy for neurodegenerative diseases

AEBISCHER PATRICK, KINGSMAN SUSAN MARY, NAYLOR STUART, MAZARAKIS NICHOLAS.

· 2001-11-08

Effect of repeated treatment with high doses of selegiline on behaviour, striatal dopaminergic transmission and tyrosine hydroxylase mRNA levels.

Themann C, Alvarez Fischer D, Gross S, Westermann R, Weihe E, Kuschinsky K, Schäfer H, Ferger B.

Naunyn Schmiedebergs Arch Pharmacol · 2001-11-08

DOI: 10.1007/s00210-001-0492-zPMID: 11862330

CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes.

Hidestrand M, Oscarson M, Salonen JS, Nyman L, Pelkonen O, Turpeinen M, Ingelman-Sundberg M.

Drug Metab Dispos · 2001-11-01

PMID: 11602525

Bilateral pallidotomy for treatment of Parkinson's disease induced corticobulbar syndrome and psychic akinesia avoidable by globus pallidus lesion combined with contralateral stimulation.

Merello M, Starkstein S, Nouzeilles MI, Kuzis G, Leiguarda R.

J Neurol Neurosurg Psychiatry · 2001-11-01

DOI: 10.1136/jnnp.71.5.611PMID: 11606671

Delay of simple reaction time after levodopa intake.

Müller T, Benz S, Börnke C.

Clin Neurophysiol · 2001-11-01

DOI: 10.1016/s1388-2457(01)00653-8PMID: 11682352

Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase.

Burkhard P, Dominici P, Borri-Voltattorni C, Jansonius JN, Malashkevich VN.

Nat Struct Biol · 2001-11-01

DOI: 10.1038/nsb1101-963PMID: 11685243